Cytomel
NDC 60793-115, liothyronine sodium, tablet, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 60793-115
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA010379
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60793-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM5 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60793-115-01 | 60793011501 | 100 TABLET in 1 BOTTLE (60793-115-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/51452b31-ff68-4e0c-b982-c15502ebf1d3NADAC price for package 60793011501
GET /v1/drugs/nadac/60793011501
Use it
Look up 60793-115 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60793-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60793-115. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.